Evidence map›Paper›PMID 37513651›Full record

ArticleNutrients2023

Peonidin-3-

Keila C Ostos Mendoza, Karen D Garay Buenrostro, Pinal N Kanabar, Mark Maienschein-Cline, Nina S Los, Zarema Arbieva, Nishikant A Raut, Temitope O Lawal, Alice M López, Paulina Cabada-Aguirre and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 4 countries.

Keila C Ostos MendozaSchool of Medicine and Health Sciences, Tecnológico de Monterrey, Av. Ignacio Morones Prieto 3000, Sertoma, Monterrey 64710, N.L., Mexico.
Karen D Garay BuenrostroSchool of Medicine and Health Sciences, Tecnológico de Monterrey, Av. Ignacio Morones Prieto 3000, Sertoma, Monterrey 64710, N.L., Mexico.
Pinal N KanabarResearch Informatics Core, Research Resources Center, University of Illinois at Chicago, Chicago, IL 60612, USA.
Mark Maienschein-ClineResearch Informatics Core, Research Resources Center, University of Illinois at Chicago, Chicago, IL 60612, USA.
Nina S LosCore Genomics Facility, Research Resource Center, University of Illinois at Chicago, Chicago, IL 60612, USA.
Zarema ArbievaCore Genomics Facility, Research Resource Center, University of Illinois at Chicago, Chicago, IL 60612, USA.
Nishikant A RautDepartment of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612, USA.
Temitope O LawalDepartment of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL 60612, USA.
Alice M LópezClinical Pharmacognosy Laboratory, Department of Pharmacy Practice, College of Pharmacy, PAHO/WHO Collaborating Centre for Traditional Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.
Paulina Cabada-AguirreClinical Pharmacognosy Laboratory, Department of Pharmacy Practice, College of Pharmacy, PAHO/WHO Collaborating Centre for Traditional Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0001-6073-9059
Diego A Luna-VitalInstitute for Obesity Research, Tecnologico de Monterrey, Monterrey 64710, N.L., Mexico.
Gail B MahadyClinical Pharmacognosy Laboratory, Department of Pharmacy Practice, College of Pharmacy, PAHO/WHO Collaborating Centre for Traditional Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.ORCID 0000-0003-1820-5963
University of Illinois Chicago · USRashtrasant Tukadoji Maharaj Nagpur University · INTecnológico de Monterrey · MXUniversity of Ibadan · NG

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
NCATS NIH HHS UL1 TR002003
6 · The paper itself

Abstract

High-throughput RNA-sequencing can determine the impact of nutrients and their combinations on gene transcription levels in osteocytes, and clarify the biological pathways associated with their impact on bone tissues. Previously, we reported that resveratrol (RES) and peonidin-3-

Indexed as

OsteoblastsOsteogenesisAnimalsAnthocyaninsApoptosisCell DifferentiationCells, CulturedGlucosidesHumansResveratrolRNAAnthocyaninsGlucosidespeonidin 3-glucosideResveratrolRNAapoptosisBcl-2DLX5HIF1αIL-18osteoporosisRanklRNA-seqSp7/osterix

Identifiers

PMID37513651
PMCPMC10383121
OpenAlexW4385172410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.